Sigrid Machherndl‐Spandl

Time-dependent changes in mortality and transformation risk in MDS

Michael Pfeilstöcker, Heinz Tuechler, Guillermo Sanz et al. · Blood · 2016 · 175 citations · Full text

Public Health, Biostatistics, Survival Analysis +10

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Lisa Pleyer, Sonja Burgstaller, Michael Girschikofsky et al. · Annals of Hematology · 2014 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

Andrea Kuendgen, Meritxell Nomdedéu, Heinz Tuechler et al. · Leukemia · 2020 · 74 citations · Full text

Medicine, Oncology, Clinical Classification Systems +16

Midostaurin plus intensive chemotherapy for younger and older patients with AML and <i>FLT3</i> internal tandem duplications

Hartmut Döhner, Daniela Weber, Julia Krzykalla et al. · Blood Advances · 2022 · 70 citations · Full text

Medicine, Hematology, Oncology +14

New data shed light on Y‐loss‐related pathogenesis in myelodysplastic syndromes

Christina Ganster, D. Kämpfe, Klaus Jung et al. · Genes Chromosomes and Cancer · 2015 · 62 citations

Medicine, Hematology, Pathology +13